Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Spero Therapeutics Stock (NASDAQ: SPRO) stock price, news, charts, stock research, profile.
Open | $1.35 |
Close | $1.37 |
Volume / Avg. | 76.74K / 132.81K |
Day Range | $1.33 - $1.43 |
52 Wk Range | 0.99 - 1.89 |
Market Cap | $71.34M |
P/E Ratio | 3.94 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 0.8% |
Days to Cover | 4.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.
Other companies in Spero Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Cellectar Biosciences (NASDAQ:CLRB), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
Spero Therapeutics has a consensus price target of $5.67.
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.32 last updated August 22, 2024 at 4:30 AM EDT.
A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
Spero Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Spero Therapeutics.
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.